Provider Networks
Expert articles and analysis related to provider networks.
AI Summary — Last 30 Days
CMS is signaling a more aggressive shift from fragmented fee-for-service incentives toward accountable, network-based payment: the proposed 2027 Medicare Physician Fee Schedule would increase support for primary care, move toward phasing out MIPS, and expand ACO participation, while ACO REACH’s reported nearly $1B in 2024 savings gives the Trump administration evidence to defend and scale risk-bearing models (CMS physician pay/ACO proposal, ACO REACH savings.
Related Articles
How Foreign Reference Pricing Embeds Valuations And Risks Undermining Global Innovation
That is the title of my new Health Affairs Forefront piece out today with Lou Garrison and Richard Xie. An excerpt from the article is below: United States policy makers increasingly argue that Americ...
CMS Proposes Rule to Govern the “Medicare Drug Price Negotiation Program”
CMS Proposes Rule to Govern the “Medicare Drug Price Negotiation Program” King & Spalding
Hospitals irate after Eli Lilly follows through on 340B ultimatum
The drugmaker stopped paying 340B discounts to hospitals that didn’t comply with its new paperwork requirements late last week. Hospitals are urging HRSA to step in.
Seven Rural Kansas Hospitals Form Clinically Integrated Network to Advance Value-Based Care
Seven Rural Kansas Hospitals Form Clinically Integrated Network to Advance Value-Based Care Digital Health News
Rural, independent Kansas hospitals launch clinically integrated network
Rural, independent Kansas hospitals launch clinically integrated network Fierce Healthcare
FTC Takes Action to Protect Americans from Higher Drug Costs in Aurobindo, Lannett Deal - Federal Trade Commission (.gov)
FTC Takes Action to Protect Americans from Higher Drug Costs in Aurobindo, Lannett Deal Federal Trade Commission (.gov)
Florida launches probe into CVS for alleged anticompetitive pharmacy practices
The investigation by Florida’s attorney general comes as states look to check pharmacy benefit managers for allegedly driving up drug costs.
PCMA sues to exempt PBMs from Illinois drug law
The drug middlemen lobby has had a busy week. It’s the second major lawsuit the PCMA has filed against a state law reforming the PBM industry since Monday.
Could PBM Reform Actually Lower Net Drug Costs?
Could PBM Reform Actually Lower Net Drug Costs? Pharmaceutical Commerce
Eli Lilly follows through on threat to withhold 340B discounts
Eli Lilly follows through on threat to withhold 340B discounts Healthcare Finance News